American Journal of Cardiology
Volume 105, Issue 3 , Pages 352-358 , 1 February 2010

Age-Modification of Lipoprotein, Lipid, and Lipoprotein Ratio-Associated Risk for Coronary Artery Calcium (from the Multi-Ethnic Study of Atherosclerosis [MESA])

  • Pathmaja Paramsothy, MD

      Affiliations

    • Department of Medicine, Division of Cardiology, University of Washington, Seattle, Washington
    • Corresponding Author InformationCorresponding author: Tel: (206) 744-9119; fax: (206) 744-9989
    • ,
  • Ronit Katz, PhD

      Affiliations

    • Department of Biostatistics, University of Washington, Seattle, Washington
    • ,
  • David S. Owens, MD

      Affiliations

    • Department of Medicine, Division of Cardiology, University of Washington, Seattle, Washington
    • ,
  • Gregory L. Burke, MD, MS

      Affiliations

    • Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina
    • ,
  • Jeffrey L. Probstfield, MD

      Affiliations

    • Department of Medicine, Division of Cardiology, University of Washington, Seattle, Washington
    • ,
  • Kevin D. O'Brien, MD

      Affiliations

    • Department of Medicine, Division of Cardiology, University of Washington, Seattle, Washington

Received 16 July 2009 ,Revised 20 September 2009 ,Accepted 20 September 2009.

References 

  1. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol. 2002;156:871–881
  2. Nelson JC, Kronmal RA, Carr JJ, McNitt-Gray MF, Wong ND, Loria CM, et al. Measuring coronary calcium on CT images adjusted for attenuation differences. Radiology. 2005;235:403–414
  3. McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2006;113:30–37
  4. Carr JJ, Nelson JC, Wong ND, McNitt-Gray M, Arad Y, Jacobs DR, et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology. 2005;234:35–43
  5. Owens DS, Katz R, Johnson E, Shavelle DM, Probstfield JL, Takasu J, et al. Interaction of age with lipoproteins as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis. Arch Intern Med. 2008;168:1200–1207
  6. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139:802–809
  7. McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?. Am J Cardiol. 2005;96:399–404
  8. McClelland RL, Kronmal RA, Haessler J, Blumenthal RS, Goff DC. Estimation of risk factor associations when the response is influenced by medication use: an imputation approach. Stat Med. 2008;27:5039–5053
  9. Loria CM, Liu K, Lewis CE, Hulley SB, Sidney S, Schreiner PJ, et al. Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA study. J Am Coll Cardiol. 2007;49:2013–2020
  10. Pletcher MJ, Tice JA, Pignone M, Browner WS. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med. 2004;164:1285–1292
  11. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336–1345
  12. Krumholz HM, Seeman TE, Merrill SS, Mendes de Leon CF, Vaccarino V, Silverman DI, et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA. 1994;272:1335–1340
  13. Schenker MP, Dorbala S, Hong EC, Rybicki FJ, Hachamovitch R, Kwong RY, et al. Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study. Circulation. 2008;117:1693–1700
  14. Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation. 2008;117:2938–2948
  15. Huang H, Virmani R, Younis H, Burke AP, Kamm RD, Lee RT. The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation. 2001;103:1051–1056
  16. Vengrenyuk Y, Carlier S, Xanthos S, Cardoso L, Ganatos P, Virmani R, et al. A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps. Proc Natl Acad Sci USA. 2006;103:14678–14683
  17. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;47:C13–C18
  18. Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol. 2009;54:49–57
  19. Korosoglou G, Weiss RG, Kedziorek DA, Walczak P, Gilson WD, Schar M, et al. Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using “positive contrast” magnetic resonance imaging. J Am Coll Cardiol. 2008;52:483–491
  20. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation (A possible explanation for the paradox of arterial calcification in osteoporotic patients). Arterioscler Thromb Vasc Biol. 1997;17:680–687
  21. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab. 2004;286:E686–E696
  22. Cola C, Almeida M, Li D, Romeo F, Mehta JL. Regulatory role of endothelium in the expression of genes affecting arterial calcification. Biochem Biophys Res Commun. 2004;320:424–427
  23. Sangiorgi G, Rumberger JA, Severson A, Edwards WD, Gregoire J, Fitzpatrick LA, et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol. 1998;31:126–133
  24. Taylor AJ, Bindeman J, Feuerstein I, Cao F, Brazaitis M, O'Malley PG. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. J Am Coll Cardiol. 2005;46:807–814
  25. Raggi P, Callister TQ, Shaw LJ. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arterioscler Thromb Vasc Biol. 2004;24:1272–1277
  26. Kondos GT, Hoff JA, Sevrukov A, Daviglus ML, Garside DB, Devries SS, et al. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation. 2003;107:2571–2576
  27. Arad Y, Spadaro LA, Roth M, Newstein D, Guerci AD. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. J Am Coll Cardiol. 2005;46:166–172
  28. Houslay ES, Cowell SJ, Prescott RJ, Reid J, Burton J, Northridge DB, et al. Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial. Heart. 2006;92:1207–1212
  29. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals. a randomised placebo-controlled trial. Lancet. 2002;360:7–22
  30. Anum EA, Adera T. Hypercholesterolemia and coronary heart disease in the elderly: a meta-analysis. Ann Epidemiol. 2004;14:705–721

 This research was supported by contracts N01-HC-95159 through N01-HC-95165 and N01-HC-95167 from the National Heart, Lung and Blood Institute, Bethesda, Maryland. Dr. Paramsothy is funded by grant 1KL2RR025015-01 from the National Center for Research Resources, a component of the National Institutes of Health, and National Institutes of Health Roadmap for Medical Research, Bethesda, Maryland. Dr. Paramsothy has received grant support from Pfizer Pharmaceuticals, New York, New York, that was not directly for support of this project. Dr. O'Brien has received speaking honoraria or grant support from AstraZeneca, Bristol Myers-Squibb, Merck, and Abbott Pharmaceuticals.

 Its contents are solely the responsibility of the authors and do not necessarily represent the official view of National Center for Research Resources or National Institutes of Health.

PII: S0002-9149(09)02411-4

doi: 10.1016/j.amjcard.2009.09.040

American Journal of Cardiology
Volume 105, Issue 3 , Pages 352-358 , 1 February 2010

Article Tools

* Image Usage & Resolution